Form 4: Corvus Pharmaceuticals CEO Exercises Warrants, Acquires Shares
SEC Form 4 Filing
Richard A. Miller, CEO of Corvus Pharmaceuticals, exercised warrants to acquire shares of common stock at $3.5 per share.
Summary
- Richard A. Miller, the President and CEO of Corvus Pharmaceuticals, executed transactions involving the company's stock on May 7, 2025.
- Miller exercised warrants to acquire 559,073 shares of common stock at a price of $3.5 per share.
- Following the transaction, Miller directly owns 1,136,707 shares of Corvus Pharmaceuticals' common stock.
- Miller also indirectly owns 1,188,103 shares through the Miller-Horning Family Trust.
- The warrants were issued in connection with Miller's subscription for shares of the Issuer's Common Stock at a price of $1.7312.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The CEO exercising warrants could be seen as a positive signal, but it's not overwhelmingly so.
Positives
- The CEO's decision to exercise warrants and increase his stake in the company could be interpreted as a sign of confidence in Corvus Pharmaceuticals' future prospects.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from the CEO.
Key Dates
| Date | Description |
|---|---|
| 1985-01-25 | Date of the Miller-Horning Family Trust agreement. |
| 2024-05-06 | Date the Warrant was exercisable. |
| 2025-05-07 | Date of the transaction (exercise of warrants). |
| 2025-05-09 | Date of the Form 4 filing. |
| 2025-06-30 | Expiration date of the Warrant. |
Keywords
Corvus Pharmaceuticals, CRVS, Richard A. Miller, CEO, Form 4, Warrants, Stock, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.